Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Gross Profit: 2020-2025

Historic Gross Profit for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $95,000.

  • Silence Therapeutics' Gross Profit rose 104.44% to $95,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 158.78%. This contributed to the annual value of $31.4 million for FY2024, which is 67.49% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Gross Profit is $95,000, which was down 31.65% from $139,000 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Gross Profit ranged from a high of $2.2 billion in Q1 2021 and a low of -$2.6 million during Q2 2024.
  • Its 3-year average for Gross Profit is $4.6 million, with a median of $934,587 in 2023.
  • Over the last 5 years, Silence Therapeutics' Gross Profit had its largest YoY gain of 2,389.55% in 2024, and its largest YoY loss of 241.92% in 2024.
  • Over the past 5 years, Silence Therapeutics' Gross Profit (Quarterly) stood at $1.8 million in 2021, then crashed by 42.54% to $1.1 million in 2022, then dropped by 12.05% to $934,587 in 2023, then spiked by 2,389.55% to $23.3 million in 2024, then soared by 104.44% to $95,000 in 2025.
  • Its Gross Profit was $95,000 in Q3 2025, compared to $139,000 in Q2 2025 and $88,000 in Q1 2025.